402 related articles for article (PubMed ID: 19306605)
1. Varicella zoster virus redux.
Gelb LD
Herpes; 2009 Jan; 15(3):62-3. PubMed ID: 19306605
[TBL] [Abstract][Full Text] [Related]
2. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
3. Perspective on live varicella vaccine.
Gershon AA; Katz SL
J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
[TBL] [Abstract][Full Text] [Related]
4. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
Lu PJ; Euler GL; Harpaz R
Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
[TBL] [Abstract][Full Text] [Related]
6. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
Mills R; Tyring SK; Levin MJ; Parrino J; Li X; Coll KE; Stek JE; Schlienger K; Chan IS; Silber JL
Vaccine; 2010 Jun; 28(25):4204-9. PubMed ID: 20416263
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
9. Zoster vaccine: current status and future prospects.
Oxman MN
Clin Infect Dis; 2010 Jul; 51(2):197-213. PubMed ID: 20550454
[TBL] [Abstract][Full Text] [Related]
10. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.
Weaver BA;
J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S31-3. PubMed ID: 22086893
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster virus vaccine.
Woolery WA
Geriatrics; 2008 Oct; 63(10):6-9. PubMed ID: 18828650
[TBL] [Abstract][Full Text] [Related]
12. Varicella-zoster vaccine for the prevention of herpes zoster.
Kimberlin DW; Whitley RJ
N Engl J Med; 2007 Mar; 356(13):1338-43. PubMed ID: 17392303
[No Abstract] [Full Text] [Related]
13. [Immunization against varicella and zoster].
Floret D
Bull Acad Natl Med; 2007 Jun; 191(6):1051-64; discussion 1064-7. PubMed ID: 18402164
[TBL] [Abstract][Full Text] [Related]
14. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1528. PubMed ID: 22071592
[TBL] [Abstract][Full Text] [Related]
15. Varicella-zoster vaccine.
Senanayake SN
N Engl J Med; 2007 Jul; 357(1):89-90. PubMed ID: 17615639
[No Abstract] [Full Text] [Related]
16. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
17. Shingles vaccine.
Willison CB; Morrison LK; Mendoza N; Tyring SK
Expert Opin Biol Ther; 2010 Apr; 10(4):631-8. PubMed ID: 20113211
[TBL] [Abstract][Full Text] [Related]
18. Zoster vaccine in older adults.
Fried R
J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
[No Abstract] [Full Text] [Related]
19. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
20. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Harpaz R; Ortega-Sanchez IR; Seward JF;
MMWR Recomm Rep; 2008 Jun; 57(RR-5):1-30; quiz CE2-4. PubMed ID: 18528318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
